Drreddys Laboratories | Ativo Circulante



Current Assets Alterar Data
ANI Pharmaceuticals USD 536.29M 8.61M 2025-03
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Bayer EUR 34.83B 388M 2025-03
Canopy Growth CAD 341.08M 50.58M 2024-12
Cipla INR 232.89B 23.43B 2025-03
Corcept Therapeutics USD 438.5M 33.1M 2025-03
Drreddys Laboratories INR 253.02B 4.89B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Hikma Pharmaceutical USD 2.28B 185M 2024-06
Lonza CHF 5.44B 113M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pacira USD 759.96M 14.83M 2025-03
Prestige Brands USD 448.33M 71.16M 2025-03
Richter Gedeon HUF 641.06B 69.19B 2024-12
Sun Pharmaceuticals INR 525.94B 64.89B 2025-03
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
Teva Pharmaceutical Industries USD 11.53B 1.02B 2025-03



Drreddys Laboratories Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.